-
Acura licenses Nexafed product to MainPointe
PALATINE, Ill. — Acura Pharmaceuticals and MainPointe Pharmaceuticals last week announced that they have entered into a license agreement to have MainPointe exclusively market Nexafed and Nexafed Sinus in the US and Canada. The pseudoephedrine-containing Nexafed brand products utilize Acura's IMPEDE Technology which disrupts the extraction and conversion of the pseudoephedrine into the illicit drug, methamphetamine.
MainPointe will assume all manufacturing and commercialization activities from Acura.
-
Flu season still 'Texas big' in Lone Star State
DEERFIELD, Ill. — The Lone Star State remains the chief hold out with regard to extending a flu season that's been winding down. According to the latest Walgreens Flu Index, four of the top 10 markets still experiencing high levels of flu activity are in Texas, including three of the top five markets.
For the week of March 12, the top 10 markets for flu activity were: